What does Connect Biopharma Holdings Ltd do?

Connect Biopharma Holdings Ltd is a public company in the Pharmaceutical Preparations industry, incorporated in E9. It is registered with the SEC under CIK 0001835268 and trades on NASDAQ under the ticker CNTB.

What is Connect Biopharma Holdings Ltd's annual revenue?

Connect Biopharma Holdings Ltd reported $64,000 in revenue for fiscal year 2025, according to its 10-K filing with the SEC.

Is Connect Biopharma Holdings Ltd profitable?

Connect Biopharma Holdings Ltd reported a net loss of $55.48M in FY2025. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Connect Biopharma Holdings Ltd made?

Connect Biopharma Holdings Ltd has filed 167 documents with the SEC since 2020. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Connect Biopharma Holdings Ltd

CNTB NASDAQ CIK: 0001835268 Pharmaceutical Preparations Inc. in E9

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 167 filings →

Form	Description	Date
3	3	Mar 18, 2026
3	FORM 3	Mar 16, 2026
3	FORM 3	Mar 16, 2026
3	FORM 3	Mar 16, 2026
3	FORM 3	Mar 16, 2026
3	FORM 3	Mar 16, 2026
3	FORM 3	Mar 16, 2026
3	FORM 3	Mar 16, 2026
SCHEDULE 13G/A	—	Feb 17, 2026
SCHEDULE 13G/A	—	Feb 17, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Connect Biopharma Holdings Ltd. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Revenue: $64.0K (FY2025)
Net Income: ($55.48M) (FY2025)
Total Assets: $56.08M (FY2025)
Operating Income: ($58.07M)

Full financials →

Details

CIK: 0001835268
Ticker: CNTB
Exchange: NASDAQ
Incorporated: E9
First Filing: 2020
Total Filings: 167

Pharmaceutical Preparations rankings →